HeartCare: The Utility of Multi-Modality in Transplant Patient Care
AlloSure Lung: Donor-Derived Cell Free DNA as an Innovative Biomarker for Lung Transplant Patients
Decreasing Transplant Wait Times by Increasing Living Donation
EFI 2021 Virtual Session – Hybrid Capture Technology – Improvements with AlloSeq Tx17
EFI 2021 Virtual Session – CareDx Poster Review
EFI 2021 Virtual Session: AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
EFI 2021 Virtual Symposium – Changing the Paradigm of HLA Typing: Better Matching, Better Method
EFI 2021 Virtual Symposium – Revolutionizing Post-Transplant Monitoring: Better Outcomes start with…
EFI 2021 A streamlined AlloSeq Tx hybrid capture workflow: DNA to sequencing in a single day.
EFI 2021 Optimization of mixed pools of buccal and peripheral blood DNA for routine testing with AlloSeq Tx…
EFI 2021 New insights into MHC variability and reporting HLA homozygosity with AlloSeq Tx 17, a hybrid…
EFI 2021 Genetic risk factors in solid organ transplantation: beyond classical human leukocyte antigen
EFI 2021 Intra-Laboratory Evaluation of a Next-Generation Sequencing-Based Solution for Chimerism Monitoring
EFI 2021 4th Field Resolution Typing is Critical for Defining the MHC Haplotype Structure Between HLA-F and…
EFI 2021 AlloSeq Tx Genotyping Using DNA Extracted from Saliva.
EFI 2021 Accurate, Reproducible and Sensitive Chimerism Monitoring with NGS-based AlloSeq HCT
Cancer as a Transplant Recipient: Understand Your Risks and Learn What to Do
Managing Medications with AlloCare
2021 HLA Webinar Series #2: The role of HLA Pseudogenes, non-classical genes and non-coding sequences in…
Life After Transplant: How to Navigate Your New Routine & Take Care of Your New Kidney
COVID-19 & Vaccines for Transplant Recipients
2021 HLA Webinar Series #1: HLA typing by Hybrid Capture: A Better Method for Better Matching
CEoT Symposium 2021: AlloSure Surveillance and Relative Change Value
Health Disparities in Transplantation for Minorities